|
Volumn 69, Issue 3, 2007, Pages 706-
|
Platelet-Rich Plasma as a novel therapeutic agent in osteomyelitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYPOXIA INDUCIBLE FACTOR 1;
PROTEIN TYROSINE KINASE;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
ANGIOGENESIS;
BLOOD COMPONENT;
BLOOD COMPONENT THERAPY;
CELL DIFFERENTIATION;
CELL SURVIVAL;
ERYTHROPOIESIS;
HUMAN;
LETTER;
OSTEOMYELITIS;
PRIORITY JOURNAL;
PROGNOSIS;
THROMBOCYTE RICH PLASMA;
TREATMENT INDICATION;
BLOOD TRANSFUSION;
BONE AND BONES;
CELL DIFFERENTIATION;
CELL SURVIVAL;
HUMANS;
MODELS, BIOLOGICAL;
MODELS, THEORETICAL;
OSTEOMYELITIS;
PLATELET TRANSFUSION;
PROTEIN ISOFORMS;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 34447259364
PISSN: 03069877
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mehy.2006.07.046 Document Type: Letter |
Times cited : (9)
|
References (5)
|